Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval in Japan for a therapy for cancer based on a virus that selectively kills malignant cells.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival Eligible patients had AKT1 E17K–mutated metastatic tumors that progressed with standard ...

Post the above conversions, there are no further outstanding FCCBs /other convertible instruments.Pursuant to the High Court judgement on the Promoters - Daichi Sankyo case, Mr Malvinder Mohan ...

As of March 28 at 3:36:36 PM EDT. Market Open.

At close: March 28 at 4:00:00 PM EDT ...

Topic Editor Alex Spyropoulos received research grants from Janssen and Astra Zeneca and is a consultant for Janssen, Astra Zeneca, Bayer, Bristol Meyer Squibb, Sanofi, and Daichi Sankyo. Topic Editor ...